Intraepithelial lymphocyte regulation of epithelial cell shedding

NIH RePORTER · NIH · R21 · $193,062 · view on reporter.nih.gov ↗

Abstract

PROJECT SUMMARY. Maintenance of an intact intestinal barrier is critical to prevent microbial activation of mucosal immunity. γδ intraepithelial lymphocytes (IEL) migrate extensively within the epithelial compartment to serve as a first line of defense against luminal antigens and invasive enteric microbes. Although γδ IELs can induce epithelial proliferation, whether γδ IELs regulate cell shedding has yet to be investigated. Our preliminary data generated for this application demonstrate γδ IELs are required for pathological cell shedding in response to systemic lipopolysaccharide (LPS) exposure; however, the mechanisms regulating this process remain unclear. This proposal seeks to elucidate the role of γδ IEL migratory behavior in pathological cell shedding and begin to define the molecular mechanisms by which γδ IELs contribute to these shedding events. Specifically, we propose to investigate the spatiotemporal dynamics of γδ IEL interactions with LPS-induced shedding events, the role of γδ IEL motility in regulating shedding, and whether local γδ IEL secretion of granzyme into the extracellular matrix facilitates release of enterocytes from the basement membrane as a critical component of the shedding process. Using an integrated approach that combines cutting edge imaging technologies with cell biology and immunological techniques, these studies will be the first to identify a direct role for γδ IELs in the regulation of pathological cell shedding. These experiments will not only elucidate a novel functional role for γδ IELs in the intestinal mucosa, but also provide the basis to investigate the extent to which specific subsets of γδ IELs contribute to maintenance of the epithelial barrier as a potential area of therapeutic development to aid in mucosal healing.

Key facts

NIH application ID
9857554
Project number
5R21AI143892-02
Recipient
RBHS-NEW JERSEY MEDICAL SCHOOL
Principal Investigator
Karen Leigh Edelblum
Activity code
R21
Funding institute
NIH
Fiscal year
2020
Award amount
$193,062
Award type
5
Project period
2019-02-01 → 2022-01-31